Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 33

1.

Immunomodulation in cancer.

Hegmans JP, Aerts JG.

Curr Opin Pharmacol. 2014 Jul 7;17C:17-21. doi: 10.1016/j.coph.2014.06.007. [Epub ahead of print] Review.

PMID:
25011112
[PubMed - as supplied by publisher]
2.

Biomarkers for immune checkpoint inhibitors.

Lievense LA, Hegmans JP, Aerts JG.

Lancet Oncol. 2014 Jan;15(1):e1. doi: 10.1016/S1470-2045(13)70557-6. No abstract available.

PMID:
24384488
[PubMed - indexed for MEDLINE]
3.

Tumour-derived exosomes as antigen delivery carriers in dendritic cell-based immunotherapy for malignant mesothelioma.

Mahaweni NM, Kaijen-Lambers ME, Dekkers J, Aerts JG, Hegmans JP.

J Extracell Vesicles. 2013 Oct 24;2. doi: 10.3402/jev.v2i0.22492. eCollection 2013.

PMID:
24223258
[PubMed]
Free PMC Article
4.

Immunological profiling as a means to invigorate personalized cancer therapy.

Hegmans JP, Aerts JG.

Oncoimmunology. 2013 Aug 1;2(8):e25236. Epub 2013 Jun 10.

PMID:
24167762
[PubMed]
Free PMC Article
5.

Arginase-1 mRNA expression correlates with myeloid-derived suppressor cell levels in peripheral blood of NSCLC patients.

Heuvers ME, Muskens F, Bezemer K, Lambers M, Dingemans AM, Groen HJ, Smit EF, Hoogsteden HC, Hegmans JP, Aerts JG.

Lung Cancer. 2013 Sep;81(3):468-74. doi: 10.1016/j.lungcan.2013.06.005. Epub 2013 Jul 11.

PMID:
23850196
[PubMed - indexed for MEDLINE]
6.

Tumor-specific cytotoxic T cells are crucial for efficacy of immunomodulatory antibodies in patients with lung cancer.

Aerts JG, Hegmans JP.

Cancer Res. 2013 Apr 15;73(8):2381-8. doi: 10.1158/0008-5472.CAN-12-3932. Epub 2013 Apr 11. Review.

PMID:
23580578
[PubMed - indexed for MEDLINE]
Free Article
7.

Tumor-associated macrophages in thoracic malignancies.

Lievense LA, Bezemer K, Aerts JG, Hegmans JP.

Lung Cancer. 2013 Jun;80(3):256-62. doi: 10.1016/j.lungcan.2013.02.017. Epub 2013 Mar 13. Review.

PMID:
23489559
[PubMed - indexed for MEDLINE]
8.

Improving lung cancer survival; time to move on.

Heuvers ME, Hegmans JP, Stricker BH, Aerts JG.

BMC Pulm Med. 2012 Dec 13;12:77. doi: 10.1186/1471-2466-12-77.

PMID:
23234250
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Patient-tailored modulation of the immune system may revolutionize future lung cancer treatment.

Heuvers ME, Aerts JG, Cornelissen R, Groen H, Hoogsteden HC, Hegmans JP.

BMC Cancer. 2012 Dec 5;12:580. doi: 10.1186/1471-2407-12-580. Review.

PMID:
23217146
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Dendritic cell-based immunotherapy in mesothelioma.

Cornelissen R, Lievense LA, Heuvers ME, Maat AP, Hendriks RW, Hoogsteden HC, Hegmans JP, Aerts JG.

Immunotherapy. 2012 Oct;4(10):1011-22. doi: 10.2217/imt.12.108. Review.

PMID:
23148753
[PubMed - indexed for MEDLINE]
11.

New roads open up for implementing immunotherapy in mesothelioma.

Cornelissen R, Heuvers ME, Maat AP, Hendriks RW, Hoogsteden HC, Aerts JG, Hegmans JP.

Clin Dev Immunol. 2012;2012:927240. doi: 10.1155/2012/927240. Epub 2012 Jun 24. Review.

PMID:
22778767
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

History of tuberculosis as an independent prognostic factor for lung cancer survival.

Heuvers ME, Aerts JG, Hegmans JP, Veltman JD, Uitterlinden AG, Ruiter R, Rodenburg EM, Hofman A, Bakker M, Hoogsteden HC, Stricker BH, van Klaveren RJ.

Lung Cancer. 2012 Jun;76(3):452-6. doi: 10.1016/j.lungcan.2011.12.008. Epub 2012 Jan 9.

PMID:
22226628
[PubMed - indexed for MEDLINE]
13.

[Exosomes and cancer].

de Vrij J, Maas SL, Hegmans JP, Lamfers ML, Dirven CM, Broekman ML.

Ned Tijdschr Geneeskd. 2011;155(51):A3677. Review. Dutch.

PMID:
22200143
[PubMed - indexed for MEDLINE]
14.

Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B.

Tjwa ET, van Oord GW, Hegmans JP, Janssen HL, Woltman AM.

J Hepatol. 2011 Feb;54(2):209-18. doi: 10.1016/j.jhep.2010.07.009. Epub 2010 Sep 6.

PMID:
21095036
[PubMed - indexed for MEDLINE]
15.

COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function.

Veltman JD, Lambers ME, van Nimwegen M, Hendriks RW, Hoogsteden HC, Aerts JG, Hegmans JP.

BMC Cancer. 2010 Aug 30;10:464. doi: 10.1186/1471-2407-10-464.

PMID:
20804550
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Zoledronic acid impairs myeloid differentiation to tumour-associated macrophages in mesothelioma.

Veltman JD, Lambers ME, van Nimwegen M, Hendriks RW, Hoogsteden HC, Hegmans JP, Aerts JG.

Br J Cancer. 2010 Aug 24;103(5):629-41. doi: 10.1038/sj.bjc.6605814. Epub 2010 Jul 27.

PMID:
20664588
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Low-dose cyclophosphamide synergizes with dendritic cell-based immunotherapy in antitumor activity.

Veltman JD, Lambers ME, van Nimwegen M, de Jong S, Hendriks RW, Hoogsteden HC, Aerts JG, Hegmans JP.

J Biomed Biotechnol. 2010;2010:798467. doi: 10.1155/2010/798467. Epub 2010 May 23.

PMID:
20508851
[PubMed]
Free PMC Article
18.

Consolidative dendritic cell-based immunotherapy elicits cytotoxicity against malignant mesothelioma.

Hegmans JP, Veltman JD, Lambers ME, de Vries IJ, Figdor CG, Hendriks RW, Hoogsteden HC, Lambrecht BN, Aerts JG.

Am J Respir Crit Care Med. 2010 Jun 15;181(12):1383-90. doi: 10.1164/rccm.200909-1465OC. Epub 2010 Feb 18.

PMID:
20167848
[PubMed - indexed for MEDLINE]
19.

Protein profiling of pleural effusions to identify malignant pleural mesothelioma using SELDI-TOF MS.

Hegmans JP, Veltman JD, Fung ET, Verch T, Glover C, Zhang F, Allard WJ, T'Jampens D, Hoogsteden HC, Lambrecht BN, Aerts J.

Technol Cancer Res Treat. 2009 Oct;8(5):323-32.

PMID:
19754208
[PubMed - indexed for MEDLINE]
20.

Exosomes.

Hegmans JP, Gerber PJ, Lambrecht BN.

Methods Mol Biol. 2008;484:97-109. doi: 10.1007/978-1-59745-398-1_7.

PMID:
18592175
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk